Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial

Cited by (269)

Items 101–200 of 269

1. Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies
   Rebecca Fox, Kate Stenning, Adrian Slee, Jane Macnaughtan, Nathan A. Davies · 2022 · Analytical Biochemistry
2. Palliative Care for Patients with End-Stage Liver Disease
   Cyriac Abby Philips, Chandan Kumar Kedarisetty · 2022 · Journal of Clinical and Experimental Hepatology
3. Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis
   Rafael Paternostro, Birgit B. Heinisch, Thomas Reiberger, Mattias Mandorfer, Constanze Bardach, Katharina Lampichler, Berit Seeland, Rémy Schwarzer, Michael A Trauner, Markus Peck‐Radosavljevic et al. · 2018 · Hepatology Research
4. A Comprehensive Review of Outcome Predictors in Low MELD Patients
   Nikhilesh R. Mazumder, Kofi Atiemo, Matthew Robert Kappus, Giuseppe Cullaro, Matthew E. Harinstein, Daniela P. Ladner, Elizabeth C. Verna, Jennifer C. Lai, Josh Levitsky · 2019 · Transplantation
5. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
   Hiroteru Kamimura, Takeki Sato, Kazuki Natsui, Takamasa Kobayashi, Tomoaki Yoshida, Kenya Kamimura, Atsunori Tsuchiya, Toshiko Murayama, Junji Yokoyama, Hirokazu Kawai et al. · 2021 · International Journal of Molecular Sciences
6. Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration
   Mathis Grossmann, Channa Nalin Jayasena, Bradley David Anawalt · 2023 · The Journal of Clinical Endocrinology & Metabolism
7. Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
   Alexander T Kusnik, Amulya Penmetsa, Farooq Chaudhary, Keerthi Renjith, Gopal A. Ramaraju, Marie A. Laryea, Johane P. Allard · 2024 · Gastroenterology Research
8. Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
   Ross Apostolov, Emily Gianatti, Darren J Wong, Numan Kutaiba, Paul John Gow, Mathis Grossmann, Marie J. Sinclair · 2022 · World Journal of Hepatology
9. Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target?
   Guillaume Hénin, Nicolas Lanthier, Géraldine Dahlqvist · 2022 · Acta gastro-enterologica belgica
10. Frailty in outpatients with cirrhosis: A prospective observational study
    Eva María Román, Marc Parramón, Montserrat Flavià, Cristina Gely, María Poca, Adolfo Gallego, Rosalía Santesmases‐Masana, Elvira Hernández Martínez-Esparza, Juan Camilo Nieto, Eulàlia Urgell et al. · 2020 · Liver International
11. The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments
    Venkatesh, Varun S., Grossmann, Mathis, Zajac, Jeffrey D., Davey, Rachel A. · 2022 · Obesity Reviews
12. Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis
    Maiko Namba, Akira Hiramatsu, Hiroshi Aikata, Kenichiro Kodama, Shinsuke Uchikawa, Kazuki Ohya, Kei Morio, Hatsue Fujino, Takashi Nakahara, Eisuke Murakami et al. · 2019 · Journal of Gastroenterology
13. Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
    Mark Wayne Sonderup, Patrick S. Kamath, Yaw Asante Awuku, Hailemichael Desalegn, Neliswa A. Gogela, Leolin Katsidzira, Christian Tzeuton, Bilal Bobat, Chris Kassianides, C Wendy Spearman · 2024 · The Lancet. Gastroenterology & hepatology
14. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease
    Yun Kim · 2021 · Life
15. Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list
    Ezequiel Mauro, Juan Manuel Diaz, Lucrecia Garcia‐Olveira, Juan Carlos Spina, Lorena Savluk, Fernanda Zalazar, Julia Mariel Saidman, Martín de Santibañes, Juan Pekolj, Eduardo de Santibáñes et al. · 2022 · Hepatology Communications
16. Sarcopenia in cirrhosis: From pathophysiology to interventional therapy
    Huiling Chen, Chenyun Yang, Shijie Yan, Xintao Liu, Ligang Zhou, Xinlu Yuan · 2024 · Experimental Gerontology
17. The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy
    Jasmohan Singh Bajaj, Andrew Fagan, Edith A. Gavis, Travis Mousel, Mary Leslie Gallagher, Puneet Puri, Michael A. Fuchs, Brian Davis, Phillip B. Hylemon, Huiping Zhou et al. · 2024 · Hepatology Communications
18. Metabolic-Associated Fatty Liver Disease and Sarcopenia
    Triada Bali, Lampros Chrysavgis, Εvangelos Cholongitas · 2023 · Endocrinology and Metabolism Clinics of North America
19. Effects of Testosterone Replacement Therapy on Muscle Strength in Older Men with Low to Low-Normal Testosterone Levels: A Systematic Review and Meta‐Analysis
    Ta-Wei Lee, Pei‐Yu Kao, Yang‐Ching Chen, Sen‐Te Wang · 2023 · Gerontology
20. Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial
    Rakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, Jaya Benjamin, Rakhi Maiwall, Ankur Jindal, Ashok Kumar Choudhary, Rajan Vijayaraghavan, Vinod Arora, Ankit Bhardwaj et al. · 2021 · Hepatology International
21. Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
    Benjamin J. Bruno, Joshua C. Weavil, Jonathan Ogle, Nachiappan Chidambaram, Elizabeth J. Carey, Christopher J. Danford, Zachary P. Fricker, Joseph Galati, William M. Lee, Parvez Mantry et al. · 2024 · Hepatology
22. Frailty and Sarcopenia in Acute‐on‐Chronic Liver Failure
    Lorena Puchades, Julia Herreras López, Maria Àngels Cebrià i Iranzo, Natalia Cezón Serrano, Tommaso Di Maira, Marina Berenguer · 2021 · Hepatology Communications
23. Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis—Pathogenesis, Implications and Therapeutic Opportunities
    Ryma Terbah, Adam Testro, Paul John Gow, Avik Majumdar, Marie J. Sinclair · 2023 · Nutrients
24. Testosterone therapy in older men: clinical implications of recent landmark trials
    Mathis Grossmann, Bradley D. Anawalt, Bu Beng Yeap · 2024 · European Journal of Endocrinology
25. Frailty in Patients With Cirrhosis
    Beverley Kok, Puneeta Tandon · 2018 · Current Treatment Options in Gastroenterology
26. Sarcopenia in Liver Transplantation: an Update
    Amritpal Dhaliwal, Felicity Rhian Williams, Omar El‐Sherif, Matthew James Armstrong · 2020 · Current Hepatology Reports
27. Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list
    Gonzalo Gómez Perdiguero, Juan Carlos Spina, Jorge Martínez, Lorena Savluk, Julia Mariel Saidman, Mariano Bonifacio, Sofia Maria Bakken, Marlene Padilla, Elena Gallego-Clemente, Víctor Moreno‐González et al. · 2023 · JHEP Reports
28. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis
    Christian Skou Eriksen, Nina Kimer, Charlotte Suetta, Søren Møller · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
29. Impact of Liver and Pancreas Diseases on Nutritional Status
    Pablo Cañamares‐Orbís, Vanesa Bernal Monterde, Olivia Sierra Gabarda, Diego Casas Deza, Guillermo García‐Rayado, Luis Cortés, Alberto Luè · 2021 · Nutrients
30. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?
    Silvia Nardelli, Stefania Gioia, Lorenzo Ridola, Michele Carlin, Antonio Davide Cioffi, Manuela Merli, Alessandra Spagnoli, Oliviero Riggio · 2021 · Digestive and Liver Disease
31. Comparison of Prognostic Impact between the Child-Pugh Score and Skeletal Muscle Mass for Patients with Liver Cirrhosis
    Hiroki Nishikawa, Hirayuki Enomoto, Akio Ishii, Yoshinori Iwata, Yuho Miyamoto, Noriko Kawamura Ishii, Yukihisa Yuri, Kunihiro Hasegawa, Chikage Nakano, Takashi Nishimura et al. · 2017 · Nutrients
32. Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment
    Alessia Lena, Sara Hadzibegovic, Stephan von Haehling, Jochen Springer, Andrew J.S. Coats, Markus S. Anker · 2021 · Polskie Archiwum Medycyny Wewnętrznej
33. A Comprehensive Review of Essential Aspects of Molecular Pathophysiological Mechanisms with Emerging Interventions for Sarcopenia in Older People
    Priyanka Prajapati, Anand Kumar, Rishabh Chaudary, Shubhada V Mangrulkar, Malti Arya, Sapana Kushwaha · 2023 · Current Molecular Pharmacology
34. Sarcopenia in end-stage liver disease and after liver transplantation
    Sofie Leunis, Marieke Vandecruys, Amaryllis H. Van Craenenbroeck, Véronique Cornelissen, Stijn Bogaerts, Stefan De Smet, Diethard R.L. Monbaliu · 2023 · Acta gastro-enterologica belgica
35. Should Sarcopenia Increase Priority for Transplant or Is It a Contraindication?
    Guido Stirnimann, Maryam Ebadi, Puneeta Tandon, Aldo J. Montaño‐Loza · 2018 · Current Gastroenterology Reports
36. S2k-Leitlinie Klinische Ernährung in der Hepatologie
    Mathias Plauth, Lars P. Bechmann, Donata Grajecki, Felix Gundling, Ludwig Kramer, Andreas Emanuel Kremer, Monika Rau, Andrea Schneider, Frank Tacke, Ingo van Thiel · 2024 · Aktuelle Ernährungsmedizin
37. Androgen receptor regulates the proliferation of myoblasts under appropriate or excessive stretch through IGF-1 receptor mediated p38 and ERK1/2 pathways
    Shaoting Fu, Xiaojing Lin, Lijun Yin, Xiaohui Wang · 2021 · Nutrition & Metabolism
38. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates
    Naga Swetha Samji, Rajiv Prakash Heda, Sanjaya Kumar Satapathy · 2019 · Translational Gastroenterology and Hepatology
39. Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis
    Yi Liu, Fanpu Ji, Mindie H. Nguyen · 2023 · Current Opinion in Gastroenterology
40. Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials
    Aayushi Sood, Alireza Hosseinpour, Akshit Sood, Sreekant Avula, Jawahar Durrani, Vishal Bhatia, Rahul Gupta · 2023 · Endocrine Practice
41. Sarcopenia is associated with short‐ and long‐term mortality in patients with acute‐on‐chronic liver failure
    Fan Zeng, Wei Jiang, Xiujun Chang, Fuxun Yang, Xiaoxiu Luo, Rongan Liu, Lei Yu, Jiajia Li, Chun Shui Pan, Xiaobo Huang et al. · 2024 · Journal of Cachexia Sarcopenia and Muscle
42. Sarcopenia—The Impact on Physical Capacity of Liver Transplant Patients
    Maciej Miarka, Krzysztof Gibiński, Maciej K. Janik, Renata Główczyńska, Krzysztof Zając, Ryszard Pacho, Joanna Raszeja‐Wyszomirska · 2021 · Life
43. Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis
    Man-Qiu Mo, Zichun Huang, Zhenhua Yang, Yunhua Liao, Ning Xia, Ling Pan · 2022 · Therapeutic Advances in Endocrinology and Metabolism
44. Initial Clinical Experience With Testosterone Undecanoate Therapy (AVEED) in Men With Testosterone Deficiency in the United States
    Yonah Krakowsky, William P Conners, Emily Davidson, A. Rawji, Abraham Morgentaler · 2017 · Urology
45. Nutritional Management of a Liver Transplant Candidate
    Saurabh Mishra, Madhumita Premkumar · 2023 · Journal of Clinical and Experimental Hepatology
46. Association between elevated serum uric acid levels and high estimated glomerular filtration rate with reduced risk of low muscle strength in older people: a retrospective cohort study
    Yu Cheng Huang, Si Liang Chen, Ying Dong, Ying Shi · 2023 · BMC Geriatrics
47. Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation
    Sophie Reichelt, Uta Merle, Miriam Klauß, Christoph Kahlert, Georg Lurje, Arianeb Mehrabi, Zoltán Czigány · 2024 · Liver International
48. Sexual health and function in liver disease
    Alberto Ferrarese, I. Hurtado-Díaz de León, Elliot B. Tapper, Patrizia Burra · 2025 · Hepatology Communications
49. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis—An Observational Study
    Surender Singh, Sunil Taneja, Puneeta Tandon, Arka De, Nipun Verma, Madhumita Premkumar, Ajay Kumar. Duseja, Radha Krishan Dhiman, Virendra Singh · 2021 · Journal of Clinical and Experimental Hepatology
50. Sexual dysfunctions and their treatment in liver diseases
    Rakesh Kumar Jagdish · 2022 · World Journal of Hepatology
51. Hepatocellular carcinoma and sarcopenia: a narrative review
    Stephanie Revoredo, Egidio Del Fabbro · 2023 · Annals of Palliative Medicine
52. A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis
    Marta Hernández‐Conde, Elba Llop, Lucía Gómez-Pimpollo, Santiago Blanco, Rodríguez Luis, C.F. Carrillo, Christie Perelló, Marta López-Gómez, José Luis Martínez Porras, Natalia Fernández-Puga et al. · 2022 · Annals of Hepatology
53. Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia
    Seul Ki Han, Soon Koo Baik, Moon Young Kim · 2025 · Nutrients
54. Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?
    Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, Fabio Marra, Erica Nicola Lynch, Claudia Campani · 2024 · World Journal of Gastroenterology
55. Testosterone Replacement Reduces Morbidity and Mortality for Most Patients With Cirrhosis
    Elliot B. Tapper, Xi Chen, Neehar D. Parikh · 2025 · Clinical Gastroenterology and Hepatology
56. Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review
    Xiaoyu Xie, Amine Benmassaoud · 2025 · World Journal of Hepatology
57. Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis
    Nghiem B. Ha, Srilakshmi Seetharaman, Dorothea Stark Kent, Frederick Yao, Amy M. Shui, Chiung‐Yu Huang, Jeremy D Walston, Jennifer C. Lai · 2023 · Liver Transplantation
58. Chronic Liver Disease in the Older Patient—Evaluation and Management
    Daniel Anthony DiLeo, Tolga Gidener, Ayse Aytaman · 2023 · Current Gastroenterology Reports
59. Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease
    Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Taeang Arai, Korenobou Hayama, Norio Itokawa, Chisa Kondo et al. · 2024 · PLoS ONE
60. Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver
    Simone Di Cola, Saniya Khan, Lucia Lapenna, Manuela Merli · 2024 · Expert Opinion on Emerging Drugs
61. Testosterone is lower in men with non-alcoholic fatty liver disease and alcohol-related cirrhosis and is associated with adverse clinical outcomes
    Ross Apostolov, Darren J Wong, Elizabeth S. L. Low, Karl Vaz, Jessica Spurio, Thomas Worland, Dorothy Liu, Roseanne Kimberley Chan, Paul John Gow, Mathis Grossmann et al. · 2023 · Scandinavian Journal of Gastroenterology
62. Nutrition in Chronic Liver Disease
    Yala Kirthi Reddy, Benedict J. Maliakkal, Uchenna A. Agbim · 2019 · Current Treatment Options in Gastroenterology
63. The Roles of Non-Pharmacologic and Emerging Pharmacologic Management of Non-alcoholic Fatty Liver Disease and Sarcopenia: A Narrative Review
    Frederick Berro Rivera, Arcel V. Adizas, Deanna Lis Pauline F Cubarrubias, Nathan Ross B. Bantayan, Sarang Choi, Genquen Philip Carado, Edgar V. Lerma, Krishnaswami Vijayaraghavan, Marc Gregory Yu · 2024 · Journal of the ASEAN Federation of Endocrine Societies
64. Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis
    Spencer C. Harris, Jasmohan Singh Bajaj · 2025 · Gut Microbes
65. CAQ Corner: The practical assessment and management of sarcopenia, frailty, and malnutrition in patients with cirrhosis
    Sarah Wang, Ana Teresa Limón‐Miró, Christofer Cruz, Puneeta Tandon · 2022 · Liver Transplantation
66. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism)
    Farid Saad · 2017 · Advances in experimental medicine and biology
67. Evaluation of handgrip strength as a predictor of sarcopenia in patients with HCV-related cirrhosis
    Mohammed Magdy Salama, Essam Bayoumy, Moataz Mohammed Sayed, Samia Rahman, Shereen Abo Baker Saleh, Ayman Samwel Zaky, Ghada Abdelrahman Mohamed · 2023 · Egyptian Liver Journal
68. Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics
    Luca Laghi, Maria Angels Ortiz, Giacomo Rossi, Eva María Román, Carlo Mengucci, Elisabet Cantó, Lucia Biagini, Elisabet Sánchez, Maria Mulet, Álvaro García‐Osuna et al. · 2024 · Biomolecules
69. Review of Sarcopenia and Testosterone Deficiency With Chronic Liver Disease and Postoperative Liver Transplant Utility of Short-Term Testosterone Replacement Therapy
    Ashokkumar B. Jain, Danielle Haussner, Tjasa Hranjec, Fauzia Butt, Jonathan G. Stine, Anita Ankola, Hussain Al Yousif, Russell Dicristina, Karen L. Krok, Juan Arenas · 2022 · Experimental and Clinical Transplantation
70. Anabolic hormone profiles in elite military men: Robust associations with age, stress, and fatigue
    Marcus K. Taylor, Genieleah A. Padilla, Lisa M. Hernández · 2017 · Steroids
71. Liver cirrhosis and sarcopenia: a dreadful combination
    Mohammad Shafi Kuchay, José Ignacio Martínez‐Montoro, Camilo Julio Llamoza-Torres, José Carlos Fernández‐García, Bruno Ramos‐Molina · 2022 · HepatoBiliary Surgery and Nutrition
72. Assessment of sarcopenia in cirrhosis: A practical approach using thigh and psoas ultrasound, bioimpedance, and anthropometry
    Isabel Campos‐Varela, Carlos Germán Céspedes, Ester Palacio, Sergi Quiroga, Núria Rosón, Jennifer L. Dodge, Elena Vargas‐Accarino, Aitor Rodríguez-Martínez, Cristina Dopazo, Guillermo Cárdenas et al. · 2025 · Liver Transplantation
73. Decoding the mechanistic basis of liver–muscle communication in health and disease
    Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El‐Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
74. Testosterone and male rejuvenation
    Sevann Helo, Peyton Thomas, Nicholas N. Tadros · 2019 · Panminerva Medica
75. Free Testosterone Is Associated With Worse Survival in Patients With Advanced Chronic Liver Disease Awaiting Liver Transplantation
    Miguel Sogbe, Brittany B. Bromfield, Roberto Tellez, Pamela M. Bloomer, Nelson Bennett, Christopher B. Hughes, Michael A. Dunn, Astrid Ruiz‐Margáin, Andrés Duarte‐Rojo · 2025 · Liver International
76. Tale of the Frail: Understanding Frailty in Cirrhosis
    Faruq Pradhan, Natasha Narang, Michael B. Fallon · 2021 · Southern Medical Journal
77. Malnutrition and Liver Disease
    Craig James McClain, Irina Kirpich, Laura Smart · 2017 · Wiley eBooks
78. Editorial: sarcopenia in liver transplantation—our weakest patients may need the strongest push
    Nikhilesh R. Mazumder, Mary Eugenia Rinella · 2019 · Alimentary Pharmacology & Therapeutics
79. Engineered albumin host for ratiometric fluorescent indicator-displacement assay: Distinguishing testosterone from estrone and estradiol
    Yuting Luo, Linhui Peng, Lin Zhang, Zhiqing Xun, Na Li, Naiyu Liu, Yalong Wang, Xinfeng Du, Tianyi Qin, Bin Liu et al. · 2025 · Chemical Engineering Journal
80. Relationship between skeletal muscle index at the third lumbar vertebra with infection risk and long-term prognosis in patients with acute-on-chronic liver failure
    Juan Wang, Jinjia Bai, Huimin Wang, G.Z. Xu, Ruoyu Yao, Jing Li, Wenrui Zhang, Han Wang, Jia Yao, Xiaojing Ren · 2024 · Frontiers in Nutrition
81. Testosterone replacement therapy in patients with cachexia: a contemporary review of the literature
    Seyed Sajjad Tabei, Rhea Kataria, Sean Hou, Armaan Singh, Hasan Al Hameedi, Doaa Hasan, Mike Hsieh, Omer A. Raheem · 2024 · Sexual Medicine Reviews
82. Stanozolol-induced Liver Injury: A Distinctive Cholestatic Clinical and Biochemical Phenotype at Presentation
    Vinícius Nunes, María Isabel Schinoni, Fernando Bessone, M. Isabel Lucena, Inmaculada Medina‐Cáliz, Nelia Hernández, Maria C. N. Costa, Isadora Lins, Ana J. Cardoso, Barbara Freire et al. · 2025 · Journal of Clinical and Experimental Hepatology
83. The Association of Free Testosterone Levels With Frailty Metrics in Advanced Chronic Liver Disease
    Miguel Sogbe, Brittany B. Bromfield, Roberto Tellez, Pamela M. Bloomer, Jaime Omar Herrera-Caceres, Christopher B. Hughes, Michael A. Dunn, Andrés Duarte‐Rojo · 2025 · Journal of Clinical Gastroenterology
84. Chronic liver disease and hepatology care in transgender and gender diverse populations
    Thanh D. Nguyen, Whitney E. Jackson, Nitzan C. Roth, Felice Cinque, Monika Sarkar, Niharika R. Samala, Rita S. Lee, Alexandra T. Strauss, Jessica Wisocky, Keyur Patel et al. · 2026 · The Lancet. Gastroenterology & hepatology
85. One Case of Pituitary Stalk Interruption Syndrome Associated with Liver Cirrhosis
    Dong Mei Li, Huan He · 2023 · Endocrine Metabolic & Immune Disorders - Drug Targets
86. The pharmacological management of alcohol-related cirrhosis: what’s new?
    Nipun Verma, Ashwin Pachat Vinod, Ashwani Kumar Singal · 2024 · Expert Opinion on Pharmacotherapy
87. Testosterone deficiency in male organ transplant recipients
    Danly Omil-Lima, Erin Jesse, Karishma Gupta, Nicholas C. Sellke, Wade W. Muncey, Corey C. Burrelli, Ramy Abou Ghayda, Aram Loeb, Nannan Thirumavalavan · 2022 · International Journal of Impotence Research
88. The cost of sarcopenia
    Michael A. Dunn · 2017 · Transplant International
89. Sarcopenia in Liver Disease: Current Evidence and Issues to Be sResolved
    Meiyi Song, Lu Xia, Qi Liu, Mengxue Sun, Fei Wang, Changqing Yang · 2018 · Advances in experimental medicine and biology
90. Hepatic Cirrhosis
    Peter Aiden McCormick, Rajiv Jalan · 2018
91. Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy
    Manjeet Kumar Goyal, Rishi Chowdhary, Chirag Vohra, Megh Patel, Shivam Kalra, Madhav Mehta, Rachel McNulty, Kartikay Goyal, Ashita Rukmini Vuthaluru, Omesh Goyal · 2026 · World Journal of Hepatology
92. Frailty and Sarcopenia in Cirrhosis: Current Knowledge and Future Directions
    Francesca D’Arcangelo, Alberto Zanetto · 2025 · Current Hepatology Reports
93. Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis
    Thomas Worland, Penelope Hey, Darren J Wong, Ross Apostolov, Roseanne Kimberley Chan, Marie J. Sinclair, Paul John Gow · 2025 · World Journal of Hepatology
94. Treatment of Vitamin D Deficiency in Decompensated Patients with Cirrhosis Is Associated with Improvement in Frailty
    Raquel Diaz-Ruiz, María Poca, Eva María Román, Berta Cuyàs, Irene Bañares, Ángela Morales, Elvira Hernández Martínez-Esparza, Rocío Panadero, Cristina Velasco, Marta Rapado‐Castro et al. · 2025 · Medical Sciences
95. Telomere Disorders and the Liver
    Alberto Calleri, Douglas Alano Simonetto · 2025 · Clinics in Liver Disease
96. Perioperative management of patients with liver cancer complicated with sarcopenia
    Jiali Xing, Xueshuai Wan, Xinting Sang, Huayu Yang, Shunda Du · 2022 · HepatoBiliary Surgery and Nutrition
97. Analysis of the impact of female sex and muscle mass on serum creatinine and waitlist priority for liver transplantation
    Shivangi Gupta, Angus W. Jeffrey, Zhengyi Wang, Leon Anton Adams, George Garas, Gerry C. MacQuillan, Michael C. Wallace, Briohny W. Smith, Wai H. Lim, R. N. FRANCIS et al. · 2025 · Liver Transplantation
98. The diagnosis and management of portal hypertension in cirrhosis: The Gastroenterological Society of Australia consensus
    Avik Majumdar, Jacinta Holmes, Stuart Keith Roberts, Purnima Bhat, Tim Mitchell, Jeyamani Ramachandran, James P. O’Beirne, Sarah Walker, Rohit Sawhney, Nishita Jagarlamudi et al. · 2026 · Hepatology Communications
99. Protective effects of irisin in sarcopenia: a promising treatment
    Yixiao Chen, Guoqing Li, Feng Gao, Ruijiang Li, Minghui Yang, Yufeng Ge, Xinbao Wu · 2026 · Journal of Orthopaedic Translation
100. Impact of Karnofsky performance status on outcomes of patients with severe alcohol‐associated hepatitis: a propensity‐matched analysis
     Anand V. Kulkarni, Shantan Venishetty, Karan Kumar, Nitish Ashok Gurav, Somaya A. M. Albhaisi, Prateek Chhabra, Sameer Shaik, Manasa Alla, Sowmya Iyengar, Mithun Sharma et al. · 2024 · Internal Medicine Journal